Inequality and antibiotic resistance: A contractualist perspective

Area of Science:

• Public Health
• Medical Ethics
• Health Economics

Background:

• Substantial inequalities exist in antibiotic effectiveness, influenced by factors such as antibiotic resistance, access to care, and diagnostic capabilities.
• Current social, political, and economic systems contribute to uneven distribution of both the benefits and burdens associated with antibiotic use.
• These disparities raise significant ethical questions regarding fairness and justice in healthcare.

Purpose of the Study:

• To analyze the ethical justification for existing inequalities in antibiotic access and outcomes.
• To explore the distribution of benefits and burdens related to antibiotic effectiveness from a moral philosophy perspective.
• To apply contractualist theory to understand and evaluate health disparities in infectious disease management.

Main Methods:

• Philosophical analysis using contractualist ethical frameworks.
• Review of existing literature on antibiotic resistance, health inequalities, and access to medicines.
• Ethical argumentation to assess the justification of current distribution patterns.

Main Results:

• Contractualist principles suggest that current inequalities in antibiotic access and outcomes are difficult to justify.
• The distribution of risks (e.g., antibiotic resistance) and benefits (e.g., effective treatment) is ethically problematic.
• Existing social, political, and economic structures perpetuate unjust disparities.

Conclusions:

• Significant ethical concerns arise from the unequal distribution of antibiotic benefits and burdens.
• A contractualist perspective highlights the need for more equitable systems in antibiotic stewardship and access.
• Addressing these inequalities is crucial for achieving global health justice.